Reckitt Benckiser Group (OTCMKTS:RBGLY) Rating Reiterated by Societe Generale

Societe Generale restated their sell rating on shares of Reckitt Benckiser Group (OTCMKTS:RBGLY) in a research report report published on Wednesday, The Fly reports.

A number of other equities research analysts have also issued reports on the stock. Barclays reaffirmed an overweight rating on shares of Reckitt Benckiser Group in a report on Wednesday, September 30th. Sanford C. Bernstein assumed coverage on shares of Reckitt Benckiser Group in a report on Monday, October 12th. They set an underperform rating for the company. JPMorgan Chase & Co. reaffirmed an overweight rating on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Royal Bank of Canada reaffirmed an underperform rating on shares of Reckitt Benckiser Group in a report on Wednesday, July 29th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a buy rating on shares of Reckitt Benckiser Group in a report on Thursday, September 3rd. Three equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and seven have given a buy rating to the stock. The stock presently has a consensus rating of Hold and an average target price of $21.00.

OTCMKTS RBGLY opened at $18.44 on Wednesday. Reckitt Benckiser Group has a 12 month low of $12.76 and a 12 month high of $21.00. The stock has a market cap of $65.59 billion, a price-to-earnings ratio of 20.49 and a beta of 0.69. The company’s 50 day moving average is $19.27 and its two-hundred day moving average is $18.52. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 1.12.

The firm also recently declared a Semi-Annual dividend, which was paid on Tuesday, October 6th. Stockholders of record on Friday, August 21st were issued a $0.175 dividend. The ex-dividend date of this dividend was Thursday, August 20th. Reckitt Benckiser Group’s dividend payout ratio is currently 37.78%.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Further Reading: The benefits and drawbacks of dollar cost averaging

The Fly

Analyst Recommendations for Reckitt Benckiser Group (OTCMKTS:RBGLY)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.